Intestinal inflammatory and redox responses to the perioperative administration of teduglutide in rats-Reference-Cited by-同舟云学术

Intestinal inflammatory and redox responses to the perioperative administration of teduglutide in rats

Published:2017-08 Issue:8 Volume:32 Page:648-661
ISSN:0102-8650
Container-title:Acta Cirurgica Brasileira
language:
Short-container-title:Acta Cir. Bras.

Author:

Costa Beatriz Pinto da¹,Gonçalves Ana Cristina²,Abrantes Ana Margarida²,Matafome Paulo²,Seiça Raquel²,Sarmento-Ribeiro Ana Bela²,Botelho Maria Filomena²,Castro-Sousa Francisco¹

Affiliation:

1. Centro Hospitalar e Universitário de Coimbra, Portugal

2. Universidade de Coimbra, Portugal

Publisher

FapUNIFESP (SciELO)

Subject

Surgery

Link

http://www.scielo.br/pdf/acb/v32n8/1678-2674-acb-32-08-00648.pdf

Reference40 articles.

1. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2;Drucker DJ;Annu Rev Physiol,2014

2. Teduglutide a review of its use in the treatment of patients with short bowel syndrome;Burness CB;Drugs,2013

3. Teduglutide in Crohn's disease;Blonski W;Expert Opin Biol Ther,2013

4. Teduglutide for safe reduction of parenteral nutrient and/or fluid requirements in adults a systematic review;Naberhuis JK;JPEN J Parenter Enteral Nutr,2016

5. Current and potential therapeutic targets of glucagon-like peptide-2;Austin K;Curr Opin Pharmacol,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orphan patients with inflammatory bowel disease - when we treat beyond evidence;World Journal of Gastroenterology;2021-12-21

2. GLP-2 analog Teduglutide in active Crohn's disease and short bowel syndrome: Confirmation of anti-inflammatory role and future perspectives;Digestive and Liver Disease;2020-06